PUBLICATION/ISSUE REVIEW COMPLETE
on 24 Oct 2024
Last Applicant/ Owned by
400 Technology Square
Cambridge
MA
02139
Serial Number
98195945 filed on 25th Sep 2023
Registration Number
N/A
Correspondent Address
Christina Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
REMSEQ
development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, devel Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
development of gene-based medicines; gene therapy and modulation research; laboratory research in the fields of degrading and enhancing RNA including exon skipping and rescue genetic lesions; Medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations for the use in gene therapy for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; preparations for detecting mutation in RNA genes for medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98195945
Mark Type
No Service/Collective Mark
Attorney Docket Number
No R08262000101
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Oct 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 21st Oct 2024 | EXAMINER'S AMENDMENT ENTERED |
| 21st Oct 2024 | EXAMINERS AMENDMENT E-MAILED |
| 21st Oct 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 21st Oct 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 03rd Oct 2024 | FINAL REFUSAL E-MAILED |
| 03rd Oct 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 03rd Oct 2024 | FINAL REFUSAL WRITTEN |
| 23rd Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 23rd Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |